Glucocorticoid impact on cochlear function and systemic side effects in autoimmune C3.MRL-Faslpr and normal C3H/HeJ mice

Hearing Research

Volumn 226, Issue 1-2, 2007, Pages 209-217

  Trune, Dennis R ^a   Kempton, J Beth ^a   Harrison, Andrew R ^a   Wobig, John L ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Autoimmune hearing loss; C3.MRL Faslpr autoimmune mice; C3H HeJ mice; Prednisolone; Steroid side effects; Systemic lupus erythematosus

Indexed keywords

GLUCOCORTICOID; PREDNISOLONE; PREDNISOLONE SODIUM PHOSPHATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN ANTIBODY COMPLEX; ARTICLE; AUDITORY THRESHOLD; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BODY WEIGHT; CONTROLLED STUDY; HEARING LOSS; HEMATOCRIT; HEMATOPOIESIS; INNER EAR DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN WEIGHT;

EID: 33947238914     PISSN: 03785955     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.heares.2006.09.011     Document Type: Article

References (58)

1. Adams J.C. Clinical implications of inflammatory cytokines in the cochlea: a technical note. Otol. Neurotol. 23 (2002) 316-322
2. Alexiou C., Kau R.J., Luppa P., and Arnold W. Allergic reactions after systemic administration of glucocorticoid therapy. Arch. Otolaryngol. Head Neck Surg. 124 (1998) 1260-1264
3. Alexiou C., Arnold W., Fauser C., Schratzenstaller B., Gloddeck B., Fuhrmann S., and Lamm K. Sudden sensorineural hearing loss. Does application of glucocorticoids make sense?. Arch. Otolaryngol. Head Neck Surg. 127 (2001) 253-258
4. Almawi W.Y., and Melemedjian O.D. Negative regulation of nuclear factor-κB activation and function by glucocorticoids. J. Mol. Endocrin. 28 (2002) 69-78
5. Andonopoulos A.P., Naxakis S., Goumas P., and Lygatsikas C. Sensorineural hearing disorders in systemic lupus erythematosus. A controlled study. Clin. Exp. Rheum. 13 (1995) 137-141
6. Arnold W., Senn P., Hennig M., Michaelis C., Deingruber K., Scheler R., Steinhoff H.-J., Riphagen F., and Lamm K. Novel slow- and fast-type drug release round-window microimplants for local drug application to the cochlea: an experimental study in guinea pigs. Audiol. Neuro-otol. 10 (2003) 53-63
7. Baeuerle P.A., and Baltimore D. NF-κB: ten years after. Cell 87 (1996) 13-20
8. Baldwin A.S. The NF-κB and IkB proteins: new discovery and insights. Ann. Rev. Immunol. 14 (1996) 649-681
9. Barrs D.M. Intratympanic corticosteroids for Meniere's disease and vertigo. Otolaryngol. Clin. N. Am. 37 (2004) 955-972
10. Chen C.-Y., Halpin C., and Rauch S.D. Oral steroid treatment of sudden sensorineural hearing loss: a ten year retrospective analysis. Otol. Neurotol. 24 (2003) 728-733
11. Dickens J.R.E., and Graham S.S. Meniere's disease - 1983-1989. Am. J. Otolaryngol. 11 (1990) 51-65
12. Dodson K.M., and Sismanis A. Intratympanic perfusion of the treatment of tinnitus. Otolaryngol. Clin. N. Am. 37 (2004) 991-1000
13. Doyle K.J., Bauch C., Battista R., Beatty C., Hughes G.B., Mason J., Maw J., and Musiek F.L. Intratympanic steroid treatment: a review. Otol. Neurotol. 25 (2004) 1034-1039
14. Gilkeson G.S., Ruiz P., Grudier J.P., Kurlander R.J., and Pisetsky D.S. Genetic control of inflammatory arthritis in congenic lpr mice. Clin. Immunol. Immunopathol. 53 (1989) 460-474
15. Grandis J.R., Hirsch B.E., and Wagener M.M. Treatment of idiopathic sudden sensorineural hearing loss. Am. J. Otol. 14 (1993) 183-185
16. Hargunani C.A., DeGagne J.M., Kempton J.B., and Trune D.R. Inner ear uptake and distribution of dexamethasone injected into the middle ear. Otol. Neurotol. 27 (2006) 564-569
17. Haynes B.F., Pikus A., Kaiser-Kupfer M., and Fauci A.S. Successful treatment of sudden hearing loss in Cogan's syndrome with corticosteroids. Arthrit. Rheum. 24 (1981) 501-503
18. Herr B.D., and Marzo S.J. Intratympanic steroid perfusion for refractory sudden sensorineural hearing loss. Otolaryngol. Head Neck Surg. 132 (2005) 527-531
19. Hilger J.A. Vasomotor labyrinthine ischemia. Ann. Otol. Rhinol. Laryngol. 59 (1950) 1102-1116
20. Himeno C., Komeda M., Izumikawa M., Takemura K., Yagi M., Weiping Y., Doi T., Kuriyama H., Miller J.M., and Yamashita T. Intra-cochlear administration of dexamethasone attenuates aminoglycoside ototoxicity in the guinea pig. Hear. Res. 167 (2002) 61-70
21. Hoffer M.E., Balough B.J., Gottshall K.R., Allen K., Weisskopf P., Wester D., and Balaban C. Sustained-release devices in inner ear medical therapy. Otolaryngol. Clin. N. Am. 37 (2004) 1053-1060
22. Hughes G.B., Kinney S.E., Barna B.P., and Calabrese L.H. Autoimmune reactivity in Meniere's disease: a preliminary report. Laryngoscope 93 (1983) 410-417
23. Hughes G.B., Barna B.P., Calabrese L.H., and Koo A. Immunologic disorders of the inner ear. In: Bailey B.J. (Ed). Head and Neck Surgery - Otolaryngology (1993), Lippincott, Philadelphia 1833-1841
24. Jimenez-Alonson J., Guiterrez-Cabello F., Castillo J.L., Sabio J.M., Hidalgo-Tenorio C., and Leon L.R. Letter to the editor re: ear involvement in systemic lupus erythematosus patients: a comparative study. J. Laryngol. Otol. 116 (2002) 746
25. Kastanioudakis I., Ziavra N., Voulgari P.V., Exarchakos G., Skevas A., and Drosos A.A. Ear involvement in systemic lupus erythematosus patients: a comparative study. J. Laryngol. Otol. 116 (2002) 103-107
26. Kelley V.E., and Roths J.B. Interaction of mutant lpr gene with background strain influences renal disease. Clin. Immunol. Immunopathol. 37 (1985) 220-229
27. Lamm K., and Arnold W. The effect of prednisolone and non-steroidal anti-inflammatory agents on the normal and noise-damaged guinea pig inner ear. Hear. Res. 115 (1998) 149-161
28. Lee J.H., and Marcus D.C. Nongenomic effects of corticosteroids on ion transport by stria vascularis. Audiol. Neuro-Otol. 7 (2002) 100-106
29. Ma W., Gee K., Lim W., Chambers K., Angel J.B., Kozlowski M., and Kumar A. Dexamethasone inhibits IL-12p40 production in lipopolysaccharide-stimulated human monocytic cells by down-regulating the activity of c-Jun N-terminal kinase, the activation protein-1, and NF-κB transcription factors. J. Immunol. 172 (2004) 318-330
30. McCabe B.F. Autoimmune sensorineural hearing loss. Ann. Otol. 88 (1979) 585-589
31. Mitchell C.R., Kempton J.B., Creedon T.A., and Trune D.R. Using a 56-stimulus train for the rapid acquisition of auditory brainstem responses. Audiol. Neuro-Otol. 4 (1999) 80-87
32. Murphy E.D., and Roths J.B. Autoimmunity and lymphoproliferation: induction by mutant gene lpr, and acceleration by a male-associated factor in strain BXSB mice. In: Rose N.R., Bigazzi P.E., and Warner N.L. (Eds). Genetic Control of Autoimmune Disease (1978), Elsevier, New York 207-220
33. Nadel D.M. The use of systemic steroids in Otolaryngology. ENT-Ear Nose Throat J. 75 (1996) 502-516
34. O-Uchi T., Kanzaki J., and Tsuchihashi N. Clinical analysis of steroid-responsive sensorineural hearing loss. Auris-Nasus-Larynx (Tokyo) 20 (1993) 79-93
35. Parnes L.S., Sun A.-H., and Freeman D.J. Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope Suppl. 91 (1999) 1-17
36. Rauch S.D. Intratympanic steroids for sensorineural hearing loss. Otolaryngol. Clin. N. Am. 37 (2004) 1061-1074
37. Sekiya T., Shimamura N., Suzuki S., and Hatayama T. Methylprednisolone ameliorates cochlear nerve degeneration following mechanical injury. Hear. Res. 151 (2001) 125-132
38. Sha W.C., Liou H., Tuomanen E.I., and Baltimore D. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell 80 (1995) 321-330
39. Shimazaki T., Ichimiya I., Suzuki M., and Mogi G. Localization of glucocorticoid receptors in the murine inner ear. Ann. Otol. Rhinol. Laryngol. 111 (2002) 1133-1138
40. Shimmer B.P., and Parker K.L. Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones. In: Hardman J.G., Limbird L.E., Molinoff P.B., and Ruddon R.W. (Eds). Goodman and Gilman's The Pharmacological Basis of Therapeutics. nineth ed. (1996), McGraw-Hill Companies, New York 1459-1485
41. Silverstein H., Thompson J., Rosenberg S.I., Brown N., and Light J. Silverstein MicroWick. Otolaryngol. Clin. N. Am. 37 (2004) 1019-1034
42. Sismanis A., Wise C.M., and Johnson G.D. Methotrexate management of immune-mediated cochleovestibular disorders. Otolaryngol. Head Neck Surg. 116 (1997) 146-152
43. Sperling N.M., Tehrani K., Liebling A., and Ginzler E. Aural symptoms and hearing loss in patients with lupus. Otolaryngol. Head Neck Surg. 118 (1998) 762-765
44. Tabuchi K., Oikawa K., Uemaetomari I., Tsuji S., Wada T., and Hara A. Glucocorticoids and dehydroepiandrosterone sulfate ameliorate ischemia-induced injury of the cochlea. Hear. Res. 180 (2003) 51-56
45. Tahera Y., Meltser I., Johansson P., Bian Z., Stierna P., Hansson A.C., and Canlon B. NF-κB mediated glucocorticoid response in the inner ear after acoustic trauma. J. Neurosci. Res. 83 (2006) 1066-1076
46. Takemura K., Komeda M., Yagi M., Himeno C., Izumikawa M., Doi T., Kuriyama H., Miller J.M., and Yamashita T. Direct inner ear infusion of dexamethasone attenuates noise-induced trauma in guinea pig. Hear. Res. 196 (2004) 58-68
47. Trune D.R. Mouse models for immunologic diseases of the auditory system. In: Willott J.F. (Ed). Handbook of Mouse Auditory Research: From Behavior to Molecular Biology (2001), CRC Press, Boca Raton 505-531
48. Trune D.R. Ion homeostasis and inner ear diseases. In: Hamid M.A., and Sismanis A. (Eds). Medical Otology and Neurotology. A Medical Guide to Auditory and Vestibular Disorders (2006), Thieme, New York 21-32
49. lpr autoimmune mice. Hear. Res. 155 (2001) 9-20
50. Trune D.R., Craven J.P., Morton J.I., and Mitchell C. Autoimmune disease and cochlear pathology in C3H/lpr strain mouse. Hear. Res. 38 (1989) 57-66
51. Trune D.R., Kempton J.B., and Mitchell C.R. Auditory function in the C3H/HeJ and C3H/HeSnJ mouse strains. Hear. Res. 96 (1996) 41-45
52. Trune D.R., Kempton J.B., and Mitchell C.R. Decreased auditory function in the C3H/lpr autoimmune disease mouse. Hear. Res. 95 (1996) 57-62
53. lpr autoimmune mouse. Hear. Res. 137 (1999) 160-166
54. lpr autoimmune mice prevents cochlear dysfunction. Hear. Res. 137 (1999) 167-173
55. Trune D.R., Kempton J.B., and Gross N.D. Mineralocorticoid receptor mediates glucocorticoid treatment effects in the autoimmune mouse ear. Hear. Res. 212 (2006) 22-32
56. Watanabe-Fukunaga R., Brannan C.I., Copeland N.G., Jenkins N.A., and Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356 (1992) 314-317
57. Wilson W.R., Byl F.M., and Laird N. The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double-blind clinical study. Arch. Otolaryngol. 106 (1980) 772-776
58. Yamamoto Y., and Gaynor R.B. Therapeutic potential of inhibition of the NF-[kappa]B pathway in the treatment of inflammation and cancer. J. Clin. Invest. 107 (2001) 135-142